Scandicaine en es it fr

Scandicaine Brand names, Scandicaine Analogs

Scandicaine Brand Names Mixture

  • No information avaliable

Scandicaine Chemical_Formula


Scandicaine RX_link

Scandicaine fda sheet

Scandicaine FDA

Scandicaine msds (material safety sheet)

Scandicaine MSDS

Scandicaine Synthesis Reference

No information avaliable

Scandicaine Molecular Weight

129.164 g/mol

Scandicaine Melting Point

223-226 oC

Scandicaine H2O Solubility

Freely soluble as HCl salt

Scandicaine State


Scandicaine LogP


Scandicaine Dosage Forms

Extended release tablet (500 mg or 1000 mg)

Scandicaine Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

Scandicaine Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

Scandicaine Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

Scandicaine side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

Scandicaine Patient Information

Scandicaine Organisms Affected

Humans and other mammals